Anthony David Sedgwick
Geen lopende functies
Oorsprong van het eerstegraads netwerk van Anthony David Sedgwick
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Public Company | Miscellaneous Commercial Services | 9 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Anthony David Sedgwick via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Comptroller/Controller/Auditor | |
ING Bank NV (United Kingdom) | Investment Banks/Brokers | Analyst-Equity | |
ING GROEP N.V. | Major Banks | Corporate Officer/Principal | |
PharmaVentures Ltd.
PharmaVentures Ltd. Investment ManagersFinance Pharma Ventures Ltd. provides advisory services on life sciences transactions. It offers mergers and acquisitions, licensing, strategy and valuation, and expert services. The firm's industry coverage includes pharmaceuticals, biologics, drug delivery systems, diagnostics, medical devices, including telemedicine, medical software. The company is headquartered in Oxford, the United Kingdom. | Investment Managers | Corporate Officer/Principal | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member | |
Metriopharm AG
Metriopharm AG Pharmaceuticals: MajorHealth Technology Metriopharm AG engages in the development and manufacture of pharmaceutical products. It offers pipeline, indicators and clinical trials. The company was founded by Ekkehard Brysch and Wolfgang Brysch in 2007 and is headquartered in Zurich, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer | |
E-THERAPEUTICS PLC | Biotechnology | Chief Executive Officer | |
HUME CAPITAL SECURITIES PLC | Investment Banks/Brokers | Corporate Officer/Principal | |
Dual Therapeutics LLC
Dual Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Dual Therapeutics LLC develops novel therapeutics for prostate cancer, lung cancer, and acute lymphoblastic leukemia. The company was founded in 2013 and is headquartered in Cleveland, OH. | Miscellaneous Commercial Services | Director/Board Member | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of Bath | College/University | Undergraduate Degree | |
Arthur Andersen LLP
Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
University College London | College/University | Undergraduate Degree Doctorate Degree | |
Atugen AG
Atugen AG Pharmaceuticals: MajorHealth Technology Atugen AG is a biopharmaceutical company. It develops RNAi therapeutics which focus on vivo applications in oncology and liver diseases, exploiting its proprietary oligonucleotide delivery technologies and chemically stabilized siRNA structures. Founded in 1998, the company is headquartered in Berlin, Germany | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Slater Investments Ltd.
Slater Investments Ltd. Investment ManagersFinance Slater Investments Ltd. is a small private company, founded in 1994 and based in London. Slater manages UK equity funds, available to retail investors (including ISAs and PEPs). The firm also offers managed accounts services to HNW individuals and offshore funds. | Investment Managers | Analyst-Equity | |
Hume Capital Securities Plc (Broker) | Investment Banks/Brokers | Director of Research - Equity | |
Stifel Nicolaus Europe Ltd.
Stifel Nicolaus Europe Ltd. Investment Banks/BrokersFinance Stifel Nicolaus Europe Ltd. (SNEL) is a brokerage firm headquartered in London, UK. The firm was founded in 1999 and do-business-as Keefe, Bruyette & Woods Ltd. (KBW). They are a subsidiary of Stifel Europe Holdings Ltd., ultimately owned by Stifel Financial Corp. (NYSE: SF) in the US. SNEL provides Pan-European equity research and sales and trading products for their institutional clients. | Investment Banks/Brokers | Analyst-Equity | |
WEIFA ASA | Pharmaceuticals: Major | Director/Board Member | |
University of Kent | College/University | Undergraduate Degree | |
Nuvo Research AG
Nuvo Research AG Pharmaceuticals: MajorHealth Technology Part of Apotex, Inc., Nuvo Research AG is a Swiss company that manufactures pharmaceuticals. The company is based in Fribourg, Switzerland. | Pharmaceuticals: Major | Director of Finance/CFO | |
SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Chairman | |
University of Hamburg | College/University | Graduate Degree | |
Argonaute RNA Ltd.
Argonaute RNA Ltd. Miscellaneous Commercial ServicesCommercial Services Argonaute RNA Ltd. develops safe and reliable methods of temporarily silencing target genes in different tissue cells. The company is based in Bristol, UK. Michael Khan has been the CEO of the British company since 2021. | Miscellaneous Commercial Services | Chief Executive Officer | |
University of Warwick | College/University | Corporate Officer/Principal | |
Diabetes UK | Corporate Officer/Principal | ||
PolyTherics Ltd.
PolyTherics Ltd. Pharmaceuticals: MajorHealth Technology PolyTherics Ltd. develops biomedical polymers for therapeutic applications. The company was founded by Antony Godwin, Sunil Shaunak and Steve Brocchini in 2001 and is headquartered in Babraham, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Spark Therapeutics Ireland Ltd.
Spark Therapeutics Ireland Ltd. Pharmaceuticals: MajorHealth Technology Spark Therapeutics Ireland Ltd. develops new gene medicines to treat autosomal dominant genetic diseases. Its product RhoNova, is designed for the treatment of patients with rhodopsin linked autosomal dominant retinitis pigmentosa, a debilitating, progressive form of inherited blindness resulting from a diverse array of mutations in the RHO gene. The company was founded by Jane G. Farrar, Paul Kenna, and Gearóid Tuohy and is headquartered in Dublin, Ireland. | Pharmaceuticals: Major | Chairman | |
Haptogen Ltd.
Haptogen Ltd. Pharmaceuticals: MajorHealth Technology Haptogen Ltd. manufactures biopharmaceuticals products. The company was founded by Jim Reid in 2002 and is headquartered in Aberdeen, UK. | Pharmaceuticals: Major | Corporate Officer/Principal | |
King's College London | College/University | Doctorate Degree | |
University of Cambridge | College/University | Masters Business Admin | |
ENYO Pharma SA
ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France. | Biotechnology | Chairman | |
Abcd Ltd. | Director/Board Member | ||
LYSOGENE | Miscellaneous Commercial Services | Chairman | |
OBSEVA SA | Pharmaceuticals: Major | Chairman | |
Churchill Pharmaceuticals | Director/Board Member | ||
Teva Biopharmaceuticals USA, Inc.
Teva Biopharmaceuticals USA, Inc. BiotechnologyHealth Technology Teva Biopharmaceuticals USA, Inc. develops and commercializes biological products. It uses albumin-fusion technology to develop and commercialize certain albumin-fusion proteins for therapeutic use. The company was founded by Craig A. Rosen, Steven C. Mayer, Indra Sanyal and Mark A. Rampy in 2005 and is headquartered in Rockville, MD. | Biotechnology | Director/Board Member |
Statistieken
Internationaal
Verenigd Koninkrijk | 25 |
Verenigde Staten | 7 |
Zwitserland | 4 |
Frankrijk | 4 |
Duitsland | 3 |
Sectoraal
Health Technology | 19 |
Finance | 11 |
Consumer Services | 8 |
Commercial Services | 6 |
Operationeel
Director/Board Member | 50 |
Corporate Officer/Principal | 20 |
Chairman | 12 |
Independent Dir/Board Member | 9 |
Chief Executive Officer | 9 |
Sterkste connecties
Insiders | |
---|---|
David C. U'Prichard | 49 |
Max Herrmann | 10 |
Annette Clancy | 10 |
Thomas Christély | 8 |
Georg Buchner | 7 |
Tim Freeborn | 6 |
Michael Khan | 6 |
Ahmad Mortazavi | 5 |
Jia Huey Cheng | 4 |
- Beurs
- Insiders
- Anthony David Sedgwick
- Bedrijfsconnecties